https://orcid.org/0000-0002-0089-7677
Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ismael García-Moguel, Ana Rosado, Aída Gómez-Cardeñosa, Mar Gandolfo-Cano, Teresa Robledo Echarren, Maria del Mar Moro Moro, Mª del Mar Reaño Martos, Rafael Pineda-Pineda, Marcela Valverde-Monge, Cristina Martin-Arriscado Arroba & Javier Domínguez-Ortega. (2022) Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study. Journal of Asthma and Allergy 15, pages 623-632.
Read now
Read now
Bruce C. Roberts, Christopher Rini, Rick Klug, Douglas B. Sherman, Didier Morel & Ronald J. Pettis. (2022) Novel cannula design improves large volume auto-injection rates for high viscosity solutions. Drug Delivery 29:1, pages 43-51.
Read now
Read now
Francesco Menzella, Matteo Fontana, Patrizia Ruggiero, Francesco Livrieri & Nicola Facciolongo. (2022) Home-based treatment of biologics for asthma: who, what, where, when and why. Expert Review of Respiratory Medicine 16:4, pages 419-428.
Read now
Read now
Sady Alpizar, Ayman Megally, Claudia Chen, Abhi Raj, John Downie & Gene Colice. (2021) Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma. Journal of Asthma and Allergy 14, pages 381-392.
Read now
Read now
Francesco Menzella, Emanuele Ferrari, Silvia Mariel Ferrucci, Enrico Lombardi, Silvio Alfano, Ornella Bonavita, Paolo Morini, Andrea Rizzi & Andrea Matucci. (2021) Self-administration of omalizumab: why not? A literature review and expert opinion. Expert Opinion on Biological Therapy 21:4, pages 499-507.
Read now
Read now
Georgios Hillas, Evangelia Fouka & Andriana I Papaioannou. (2020) Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab. Expert Review of Respiratory Medicine 14:4, pages 353-365.
Read now
Read now
Articles from other publishers (6)
Ming-Li Chen, Tanawin Nopsopon & Ayobami Akenroye. (2023) Incidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice 11:5, pages 1475-1484.e20.
Crossref
Crossref
Fernando Ramírez-Jiménez, Gandhi Fernando Pavón-Romero, Juancarlos Manuel Velásquez-Rodríguez, Mariana Itzel López-Garza, José Fernando Lazarini-Ruiz, Katia Vanessa Gutiérrez-Quiroz & Luis M. Teran. (2023) Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future. Pharmaceuticals 16:2, pages 270.
Crossref
Crossref
M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina & T. V. Marin. (2022) Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 15:2, pages 175-186.
Crossref
Crossref
Sergey N. Avdeev, Alexandr V. Emelyanov, Oksana M. Kurbacheva, Irina M. Marusenko, Pavel I. NovikovOlga A. Rizakhanova & Larisa V. Shul’zhenko. (2021) A new delivery device for benralizumab (autoinjector, pen-injector device) in the clinical practice of treating severe eosinophilic asthma: Conclusion of the Expert Council. PULMONOLOGIYA 31:6, pages 776-781.
Crossref
Crossref
Vanitha Sampath, Grace Rabinowitz, Mihir Shah, Surabhi Jain, Zuzana Diamant, Milos Jesenak, Ronald Rabin, Stefan Vieths, Ioana Agache, Mübeccel Akdis, Domingo Barber, Heimo Breiteneder, Sharon Chinthrajah, Tomas Chivato, William Collins, Thomas Eiwegger, Katharine Fast, Wytske Fokkens, Robyn E. O'Hehir, Markus Ollert, Liam O'Mahony, Oscar Palomares, Oliver Pfaar, Carmen Riggioni, Mohamed H Shamji, Milena Sokolowska, Maria Jose Torres, Claudia Traidl‐Hoffmann, Menno van Zelm, De Yun Wang, Luo Zhang, Cezmi A. Akdis & Kari C. Nadeau. (2021) Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives. Allergy 76:6, pages 1640-1660.
Crossref
Crossref
Genny Chaia, Ubaldo Martín, Arturo Cortés-Telles, Fernando Morett, José Julio Gutiérrez-Mujica, Adriana Zepeda-Gómez, Alberto Hegewisch & Rogelio Ramses Hernández. (2020) Benralizumab: eficacia y seguridad en pacientes con asma grave eosinofílica.. Revista Alergia México 67.
Crossref
Crossref